Table 6.
Strategy 1 (home-based) | Strategy 2 (hospital-based) | ||||||
---|---|---|---|---|---|---|---|
Actors | Objectives | Activities | Partecipation to the value creation process | Value obtained | Activities | Partecipation to the value creation process | Value obtained |
Focal | Cost vs quality | Offers the therapy at hospital | Active | (increased)public health due to increased compliance, but less medical costs per attack other than drugs due to treatment at home | Offers the therapy at hospital | Active | Public health |
Other market facing | Sales | Provides the drug and the training for patients and caregivers | Active | (increased) profits due to increased compliance | Provides the drug | Active | Profits |
Public | Cost vs quality | Funds the focal firm | Active | (increased) public health due to increased compliance, but less medical costs per attack due to treatment at home. (increased) social value due to less non-medical costs per attack |
Funds the focal firm | Active | Public health |
Personal | Quality | Involved in self-administration | Active | Value exceeding quality of care and allowing better life and social conditions | Receives the therapy | Recipient | Care |
Private | Quality | Involved in self-administration | Active | Value exceeding quality of care of the assisted patient and allowing better life and social conditions | Assists the patient | Recipient | Care of the assisted patient |